RyR2 inhibition with dantrolene is antiarrhythmic, prevents further pathological remodeling, and improves cardiac function in chronic ischemic heart disease is a research paper published in Journal of Molecular and Cellular Cardiology (2023). On theSindex it has a DataRank of 0. It has been cited 23 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 3OT2OD023848
National Institutes of Health
Grant: R35 HL144980
National Cancer Institute
Grant: P30CA068485
National Cancer Institute
Grant: S10 OD023475-01A1
American Heart Association
Grant: 19SFRN34830019
NIH HHS
Grant: S10 OD023475
NIH HHS
Grant: OT2 OD023848
Fondation Leducq
FWCI
3.99
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals